Home Newsfeeds Citigroup Maintains Neutral on Eastman Chemical, Lowers Price Target to $93

Citigroup Maintains Neutral on Eastman Chemical, Lowers Price Target to $93

Citigroup analyst PJ Juvekar maintains Eastman Chemical (NYSE:EMN) with a Neutral and lowers the price target from $102 to $93.

byBenzinga Newsdesk

September 14, 2022

1 minute read

Citigroup analyst PJ Juvekar maintains Eastman Chemical (NYSE:EMN) with a Neutral and lowers the price target from $102 to $93.

Piper Sandler Maintains Neutral on Berkshire Hills Bancorp, Raises Price Target to $31

By Benzinga Newsdesk

October 10, 10:19 AM

Piper Sandler analyst Mark Fitzgibbon maintains Berkshire Hills Bancorp (NYSE:BHLB) with a Neutral and raises the price target from $29 to $31.

BHLB

Analyst Ratings

Where Petco Health and Wellness Stands With Analysts

By Benzinga Insights

August 12, 3:03 PM

Over the past 3 months, 6 analysts have published their opinion on Petco Health and Wellness (NASDAQ:WOOF) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

WOOF

Analyst Ratings

Goldman Sachs Maintains Buy Rating for Fifth Third Bancorp: Here’s What You Need To Know

By Benzinga Insights

July 21, 1:00 PM

Goldman Sachs has decided to maintain its Buy rating of Fifth Third Bancorp (NASDAQ:FITB) and raise its price…

FITB

Nasdaq Surges Over 100 Points; G Medical Innovations Shares Plunge

By Lisa Levin

March 31, 12:02 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 100 points on Friday. The Dow traded up 0.69% to 33,086.43 while the NASDAQ rose 1.01% to 12,134.43. The S&P 500, also rose, gaining, 0.78% to 4,082.51.

CSSE

Citigroup Maintains Neutral on Eastman Chemical, Lowers Price Target to $93

Related Posts

Piper Sandler Maintains Neutral on Berkshire Hills Bancorp, Raises Price Target to $31

Where Petco Health and Wellness Stands With Analysts

Goldman Sachs Maintains Buy Rating for Fifth Third Bancorp: Here’s What You Need To Know

Nasdaq Surges Over 100 Points; G Medical Innovations Shares Plunge